Figure 6
Figure 6. Donor-derived TH1 and TH17 cells that mediate autoimmunity emerge during acute GVHD. (A) Lethally irradiated (900 cGy) Balb/c mice received transplants of TCD Balb BM plus 3 × 105 Balb spleen cells (syngeneic) (□) or TCD B6 BM (10 × 106) plus 3 × 105 B6 spleen cells (allogeneic) (■). Mice in both cohorts were bled 21 days after transplantation, and serum was analyzed for presence of IL-17, G-CSF, TNF-α, IL-6, IL-1β, and IFN-γ. Data are presented as the mean plus or minus SEM and are cumulative results from 2 experiments. (B) Lethally irradiated Balb mice were transplanted with TCD BM (10 × 106) plus 3 × 105 B6 spleen cells. At 20 days after transplantation, CD4+ T cells were purified from pooled spleen cell suspensions by magnetic bead separation. Cells were then restimulated with PMA and ionomycin in the presence of GolgiStop and then intracellularly stained with IFN-γ, IL-17, or IL-4–specific antibodies. Dot plots show the percentage of CD4+ T cells that were positive for each of these cytokines.

Donor-derived TH1 and TH17 cells that mediate autoimmunity emerge during acute GVHD. (A) Lethally irradiated (900 cGy) Balb/c mice received transplants of TCD Balb BM plus 3 × 105 Balb spleen cells (syngeneic) (□) or TCD B6 BM (10 × 106) plus 3 × 105 B6 spleen cells (allogeneic) (■). Mice in both cohorts were bled 21 days after transplantation, and serum was analyzed for presence of IL-17, G-CSF, TNF-α, IL-6, IL-1β, and IFN-γ. Data are presented as the mean plus or minus SEM and are cumulative results from 2 experiments. (B) Lethally irradiated Balb mice were transplanted with TCD BM (10 × 106) plus 3 × 105 B6 spleen cells. At 20 days after transplantation, CD4+ T cells were purified from pooled spleen cell suspensions by magnetic bead separation. Cells were then restimulated with PMA and ionomycin in the presence of GolgiStop and then intracellularly stained with IFN-γ, IL-17, or IL-4–specific antibodies. Dot plots show the percentage of CD4+ T cells that were positive for each of these cytokines.

Close Modal

or Create an Account

Close Modal
Close Modal